1. COMPARISON OF OUTCOMES BETWEEN PATIENTS WITH MYC REARRANGED DLBCL AND DOUBLE/ TRIPLE HIT HIGH‐GRADE B CELL LYMPHOMA: A PAN‐LONDON RETROSPECTIVE REVIEW. (12th June 2019) Authors: El‐Sharkawi, D.; Sharma, S.; Cook, L.; Hanley, B.; Johnston, R.; Arasaretnam, A.; Lazana, I.; Greaves, P.; Parkinson, A.; Peng, Y.; Kassam, S.; Peacock, V.; Kaczmarski, R.; Bower, M.; Cheung, B.; De Lord, C.; Cross, M.; Vroobel, K.; Wotherspoon, A.; Aldridge, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EXCELLENT OUTCOMES USING RITUXIMAB, GEMCITABINE, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISOLONE (R‐GCVP) IN PATIENTS WITH DLBCL AND CARDIAC COMORBIDITIES. (12th June 2019) Authors: Michalarea, V.; Low, R.; Kirkwood, A.A.; Harrington, P.; Yadollahi, S.; Djebbari, F.; Gleeson, M.; Cwynarski, K.; Lambert, J.; Chau, I.; Wrench, D.; Eyre, T.A.; Davies, A.; Ardeshna, K.M.; Cunningham, D.; Fields, P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PRIMARY MEDIASTINAL B CELL LYMPHOMA IN THE PROSPECTIVE IELSG 37 TRIAL. (17th June 2021) Authors: Martelli, M.; Zucca, E.; Botto, B.; Kryachok, I.; Ceriani, L.; Balzarotti, M.; Tucci, A.; Cabras, M. G.; Zilioli, V. R.; Rusconi, C.; Angrilli, F.; Arcaini, L.; Iwanicka, A. Dabrowska; Ferreri, Andrés J.M.; Merli, F.; Zhao, W.; Hodgson, D.; Ionescu, C.; Fosså, A.; Cwynarski, K. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MODIFICATION OF ESCALATED BEACOPP WITH DACARBAZINE / PROCARBAZINE SUBSTITUTION REDUCES RED CELL TRANSFUSION REQUIREMENTS AND MAY SHORTEN TIME TO MENSTRUAL PERIOD RECOVERY. (12th June 2019) Authors: Follows, G.; Santarsieri, A.; Sturgess, K.; Menne, T.; Osborne, W.; Creasey, T.; Ardeshna, K.M.; Behan, S.; Booth, S.; Collins, G.; Cwynarski, K.; Iyengar, S.; Jones, S.; Martinez‐Calle, N.; McKay, P.; Nagumantry, S.K.; O'Mahony, D.; Rudge, J.F.; Shah, N.; Stafford, G. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1460: SAFETY AND EFFICACY FINDINGS OF AUTO1, A FAST-OFF RATE CD19 CAR, IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA. (23rd June 2022) Authors: Roddie, C.; Dias, J.; O'Reilly, M.; Green, L.; Vaughan, M.; Agliardi, G.; Garcia, J.; Lewin, E.; Lowdell, M.; Mitsikakou, M.; Charalambous, E.; Hotblack, A.; Dreau, H.; Marzolini, M.; Wood, L.; Every-Clayton, C.; Lal, A.; Ngai, Y.; Popova, B.; Malhi, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. S145: THE COMBINATION OF IBRUTINIB PLUS VENETOCLAX RESULTS IN A HIGH RATE OF MRD NEGATIVITY IN PREVIOUSLY UNTREATED CLL: THE RESULTS OF THE PLANNED INTERIM ANALYSIS OF THE PHASE III NCRI FLAIR TRIAL. (23rd June 2022) Authors: Hillmen, P.; Pitchford, A.; Bloor, A.; Pettitt, A.; Patten, P.; Forconi, F.; Schuh, A.; Fox, C.; Elmusharaf, N.; Gatto, S.; Kennedy, B.; Gribben, J.; Pemberton, N.; Sheehy, O.; Preston, G.; Howard, D.; Hockaday, A.; Cairns, D.; Jackson, S.; Greatorex, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. S261: SAFETY AND PRELIMINARY EFFICACY FINDINGS OF AUTO4, A TRBC1-TARGETTING CAR, IN RELAPSED/REFRACTORY TRBC1 POSITIVE SELECTED T CELL NON-HODGKIN LYMPHOMA. (23rd June 2022) Authors: Cwynarski, K.; Tholouli, E.; Iacoboni, G.; Menne, T.; Irvine, D.; Wood, L.; Balasubramaniam, N.; Shang, J.; Zhang, M; Duffy, K.; Huber, B.; Vinson, M.; Brugger, W.; Pule, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SARS‐COV‐2 INFECTION IN 50 PATIENTS WITH PRIMARY CNS LYMPHOMA: PRESENTATION, EFFECTS ON TUMOR TREATMENT AND OUTCOME IN A SERIES OF THE INTERNATIONAL PCNSL COLLABORATIVE GROUP. (17th June 2021) Authors: Ferreri, A. J. M.; Steffanoni, S.; Calimeri, T.; Laurenge, A.; Fox, C. P.; Soussain, C.; Grommes, C.; Sassone, M. C.; Touat, M.; Boot, J.; Crosbie, N.; Chaganti, S.; Dietrich, J.; Alencar, A.; Itchaki, G.; Hoang Xuan, K.; Batchelor, T.; Cwynarski, K. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Utility of baseline assessment with FDG‐PET‐CT compared with CT Scanning in people with diffuse large B‐cell lymphoma (DLBCL). (June 2017) Authors: Cuadrado, M.; Afaq, A.; Kayani, I.; Cwynarski, K.; Lambert, J.; Townsend, W.; McNamara, C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗